Sylvia M Castro, MD
Family Practice · Livingston
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
- Since medical school
- 7 years
- Graduated 2019
Offices
4 locations · Livingston Community Health · 21 clinicians in this group
Looking this up.
Hospitals listed: Emanuel Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Castro’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A179885 · Current
Licensed to practise in California · since 2022 · expires 2028-08-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emanuel Medical CenterTurlock, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.231, Oct 2024 – Sep 2025
See every measure and the patient survey for Emanuel Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 622 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.82 (131.99 to 239.65) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.8 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 443 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 1,680 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,151 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.53 (1.2 to 5.87) · 700 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.43) · 734 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 3,326 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 45 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.908 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.836 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.997 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 307 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 461 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -12.8 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.8 · 417 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 37.9 · 472 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.1 · 524 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.9 to 7.6) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (7.4 to 12.8) · 264 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.5 to 19.3) · 257 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 289 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 14% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Medicaid work
$25,717 in 2023
Medicaid paid $25,717 for 2,492 billed services this clinician did in 2023, up to 169 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,097 | $10,192 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 269 | $5,815 |
| Short return visit (20+ min) | 591 | $4,010 |
| New patient visit (45+ min) | 79 | $2,077 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 288 | $1,454 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 75 | $1,319 |
| Screening performed and negative | 12 | $374 |
| OFF/OP EST MAY X REQ PHY/QHP | 56 | $204 |
| New patient visit (30+ min) | 12 | $196 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 13 | $76 |
| 2023 | 2,492 | 10 | 169 | $25,717 |
| 2022 | 772 | 6 | 72 | $46,466 |
| 2021 | 895 | 6 | 70 | $84,960 |
| 2020 | 394 | 3 | 45 | $44,644 |
| 2019 | 89 | 2 | 25 | $12,224 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 244 | $41,869 |
| Short return visit (20+ min) | 250 | $1,882 |
| Return visit (30+ min) | 186 | $1,790 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 24 | $512 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 45 | $226 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 23 | $187 |
2021
| Clinic visit/encounter, all-inclusive | 508 | $84,535 |
| Short return visit (20+ min) | 249 | $425 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $0 |
| Return visit (30+ min) | 93 | $0 |
| Service | 19 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 269 | $44,644 |
| Short return visit (20+ min) | 112 | $0 |
| Service | 13 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 72 | $12,224 |
| Short return visit (20+ min) | 17 | $0 |
Drugs they prescribed that Part D paid
$161,594
Pharmacies billed $161,594 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,073) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
844 generic and 212 brand-name prescriptions · $161,594 in drug cost · 29 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 12 | $41,378 | $3,448 |
| Ozempic | 36 | $37,386 | $1,038 |
| Jardiance | 23 | $22,972 | $999 |
| Eliquis | 15 | $9,745 | $650 |
| Tradjenta | 12 | $7,214 | $601 |
See all 29 drugs
| Xifaxan | 12 | $41,378 | $3,448 |
| Ozempic | 36 | $37,386 | $1,038 |
| Jardiance | 23 | $22,972 | $999 |
| Eliquis | 15 | $9,745 | $650 |
| Tradjenta | 12 | $7,214 | $601 |
| Januvia | 11 | $5,969 | $543 |
| Lactulose | 12 | $903 | $75 |
| Losartan | 123 | $894 | $7 |
| Atorvastatin | 91 | $870 | $10 |
| Diclofenac | 25 | $653 | $26 |
| Lantus Solostar | 14 | $539 | $38 |
| Levothyroxine | 38 | $476 | $13 |
| Buspirone | 17 | $354 | $21 |
| Metformin | 51 | $322 | $6 |
| Fluticasone Propionate | 31 | $273 | $9 |
| Doxepin | 18 | $264 | $15 |
| Spironolactone | 20 | $212 | $11 |
| Gabapentin | 26 | $186 | $7 |
| Propranolol | 13 | $176 | $14 |
| Amlodipine Besylate | 28 | $159 | $6 |
| Escitalopram | 22 | $153 | $7 |
| Hydrochlorothiazide | 27 | $147 | $5 |
| Pantoprazole | 14 | $128 | $9 |
| Omeprazole | 17 | $105 | $6 |
| Lisinopril | 21 | $87 | $4 |
| Carvedilol | 19 | $71 | $4 |
| Benazepril | 12 | $70 | $6 |
| Furosemide | 26 | $69 | $3 |
| Trazodone | 11 | $60 | $5 |
Year by year
| 2024 | 1,073 | 113 | 0% (0) | 20% | $161,594 |
| 2023 | 2,202 | 248 | None | 17% | $319,023 |
| 2022 | 485 | 112 | None | None | $52,454 |
| 2021 | 404 | 54 | None | None | $43,273 |
| 2020 | 306 | 46 | 0% (0) | None | $28,137 |
| 2019 | 67 | 11 | 0% (0) | None | $5,288 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Jardiance | 64 | $72,909 | $1,139 |
| Ozempic | 47 | $53,589 | $1,140 |
| Trulicity | 22 | $20,292 | $922 |
| Farxiga | 18 | $16,911 | $940 |
| Eliquis | 11 | $9,361 | $851 |
| Humulin N | 12 | $8,776 | $731 |
| Novolog Flexpen | 12 | $8,480 | $707 |
| Atorvastatin | 167 | $4,497 | $27 |
| Lantus Solostar | 11 | $3,166 | $288 |
| Metformin | 152 | $2,285 | $15 |
| Losartan | 98 | $2,248 | $23 |
| Lisinopril | 134 | $1,978 | $15 |
| Duloxetine | 23 | $1,686 | $73 |
| Levothyroxine | 107 | $1,662 | $16 |
| Mirtazapine | 26 | $1,543 | $59 |
| Diclofenac | 48 | $1,498 | $31 |
| Tamsulosin | 38 | $1,215 | $32 |
| Amlodipine Besylate | 85 | $1,151 | $14 |
| Omeprazole | 41 | $976 | $24 |
| Gabapentin | 57 | $908 | $16 |
| Pravastatin | 25 | $826 | $33 |
| Rosuvastatin | 14 | $617 | $44 |
| Chlorthalidone | 36 | $612 | $17 |
| Buspirone | 32 | $597 | $19 |
| Escitalopram | 38 | $582 | $15 |
| Metoprolol | 26 | $526 | $20 |
| Fluticasone Propionate | 25 | $483 | $19 |
| Sertraline | 30 | $443 | $15 |
| Pantoprazole | 24 | $409 | $17 |
| Azelastine | 17 | $387 | $23 |
| Hydrochlorothiazide | 47 | $323 | $7 |
| Benazepril | 16 | $316 | $20 |
| Lisinopril-Hydrochlorothiazide | 21 | $290 | $14 |
| Metoprolol | 23 | $287 | $12 |
| Trazodone | 36 | $267 | $7 |
| Spironolactone | 17 | $256 | $15 |
| Carvedilol | 16 | $248 | $15 |
| Simvastatin | 19 | $247 | $13 |
| Potassium Chloride | 11 | $244 | $22 |
| Clotrimazole | 13 | $239 | $18 |
| Nitrofurantoin Mono-Macro | 16 | $237 | $15 |
| Losartan-Hydrochlorothiazide | 14 | $220 | $16 |
| Furosemide | 19 | $177 | $9 |
| Citalopram Hbr | 13 | $128 | $10 |
| Quetiapine | 12 | $105 | $9 |
2022: 12 drugs
| Jardiance | 12 | $12,953 | $1,079 |
| Atorvastatin | 46 | $940 | $20 |
| Gabapentin | 27 | $413 | $15 |
| Metformin | 38 | $352 | $9 |
| Losartan | 19 | $334 | $18 |
| Chlorthalidone | 13 | $247 | $19 |
| Metoprolol | 13 | $172 | $13 |
| Hydrochlorothiazide | 15 | $147 | $10 |
| Metoprolol | 11 | $140 | $13 |
| Lisinopril | 21 | $105 | $5 |
| Sertraline | 12 | $103 | $9 |
| Amlodipine Besylate | 18 | $93 | $5 |
2021: 8 drugs
| Novolog Flexpen | 15 | $8,077 | $538 |
| Basaglar Kwikpen U-100 | 22 | $5,550 | $252 |
| Gabapentin | 25 | $702 | $28 |
| Atorvastatin | 29 | $271 | $9 |
| Amlodipine Besylate | 24 | $219 | $9 |
| Losartan | 18 | $214 | $12 |
| Lisinopril | 22 | $190 | $9 |
| Metformin | 23 | $143 | $6 |
2020: 5 drugs
| Basaglar Kwikpen U-100 | 12 | $3,078 | $256 |
| Gabapentin | 15 | $783 | $52 |
| Atorvastatin | 21 | $351 | $17 |
| Lisinopril | 28 | $222 | $8 |
| Metformin | 17 | $112 | $7 |
Money from drug and device companies
$80 in 2025
| 2025 | 2 | 4 | None | $80 |
| 2024 | 1 | 1 | None | $15 |
| 2023 | 3 | 3 | None | $52 |
| 2022 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Mounjaro | $54 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $26 | 1 payment
|
See all 4 published payments
| Lilly USA | Meals · 2025-06-13 | Mounjaro | $21 |
| Exact Sciences | Meals · 2025-04-18 | Cologuard Collection Kit | $26 |
| Lilly USA | Meals · 2025-04-11 | Mounjaro | $16 |
| Lilly USA | Meals · 2025-03-07 | Mounjaro | $17 |
See earlier years (2024, 2023, 2022)
2024: $15
| GlaxoSmithKline | Arexvy | $15 | 1 payment
|
2023: $52
| Cranial Technologies | Doc Band | $18 | 1 payment
|
| AbbVie | Vraylar | $18 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $16 | 1 payment
|
2022: $16
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
Professional record
- NPI
- 1609439793
- Licence
- CA A179885California A179885: Current · expires 2028-08-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 1317 Oakdale Rd Ste 440, Modesto, CA, 95355
- NPI first listed
- 2019-04-15
- NPI last updated
- 2022-06-29
- NPI record certified
- 2022-06-29
This is when the NPI record was last certified, not a medical board exam.